HIV Drug Resistance Profiles and Clinical Outcomes in Patients with Viremia Maintained at Very Low Levels

Journals Menu

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

World Journal of AIDS

ISSN Print: 2160-8814
ISSN Online: 2160-8822
www.scirp.org/journal/wja
E-mail: wja@scirp.org

Citations h5-index & Ranking*

Journals Menu

"HIV Drug Resistance Profiles and Clinical Outcomes in Patients with Viremia Maintained at Very Low Levels"
written by Michael R. Jordan, Julie Winsett, Aileen Tiro, Vuth Bau, Rony S. Berbara, Christopher Rowley, Nobel Bellosillo, Christine Wanke, Eoin P. Coakley,
published by World Journal of AIDS, Vol.3 No.2, 2013

has been cited by the following article(s):

Google Scholar
CrossRef

[1]	HIV-1 drug resistance mutations among individuals with low-level viraemia while taking combination ART in Botswana
	Steele… - Journal of …, 2022

[2]	Family APGAR and treatment outcomes among HIV patients at two ART Centres in Kumasi, Ghana
	Boateng, A Enimil, A Essuman, H Lawson… - Ghana Medical …, 2022

[3]	Human Immunodefi ciency Virus (HIV) Drug Resistance: A Global Narrative
	Journal ISSN, 2021

[4]	Persistent low-Level viremia in persons living with HIV undertreatment: An unresolved status
	Bermejo, ER de Arellano, V Lara-Aguilar… - Virulence, 2021

[5]	Feasibility and clinical relevance of HIV-1 drug resistance testing in patients with low-level viraemia in South Africa
	Journal of Antimicrobial …, 2021

[6]	Drug resistance mutations in proviral DNA of HIV-infected patients with low level of viremia
	2020

[7]	HIV-1 DRUG RESISTANCE MUTATIONS IN ANTIRETROVIRAL TREATED THAI PATIENTS WITH LOW VIRAL LOAD
	2019

[8]	Low rates of nucleoside reverse transcriptase inhibitor and nonnucleoside reverse transcriptase inhibitor drug resistance in Botswana
	2019

[9]	Correlation between Mutations at the Beginning of Treatment and Virological Failure after 6 Months of Antiretroviral Treatment in People Living with the Human …
	2018

[10]	Tuberculous meningitis is associated with higher cerebrospinal HIV-1 viral loads compared to other HIV-1-associated meningitides
	PLOS ONE, 2018

[11]	Molecular epidemiology of human immunodeficiency virus type 1 and therapeutic monitoring of patients treated in Kinshasa/Democratic Republic of the Congo
	2018

[12]	State of the Antiretroviral Therapy in Human Immunodeficiency Virus Drug Resistance: Science and Technology Knowledge Gap
	2018

[13]	Frequencies of Molecular Markers of Resistance to Non-Nucleotide Inhibitors of Reverse Transcriptase in Treatment-naive HIV-infected Patients in Kinshasa
	2018

[14]	Correlation between Mutations at the Beginning of Treatment and Virological Failure after 6 Months of Antiretroviral Treatment in People Living with the …
	2018

[15]	State of the Art in HIV Drug Resistance: Science and Technology Knowledge Gap.
	2018

[16]	Genetic Diversity and Antiretroviral Drug Resistance among Drug-Naïve HIV Type 1 Infected Patients attending Clinics in Kinshasa, Democratic Republic of …
	2015

[17]	Genetic Diversity and Antiretroviral Drug Resistance among Drug-Naïve HIV Type 1 Infected Patients attending Clinics in Kinshasa, Democratic Republic of Congo
	Journal of HIV and AIDS, 2015

[18]	Molecular Epidemiologic Profile of HIV type I Infection in treatment-naive patients in Kinshasa
	2015

[19]	HIV drug resistance detected during low-level viremia is associated with subsequent virologic failure
	AIDS (London, England), 2014

[1]	HIV-1 RNA and DNA Genotyping Drug Resistance Detection in Patients with Low-Level Viremia in Liangshan, China AIDS Research and Human Retroviruses, 2023 DOI:10.1089/aid.2022.0140

[2]	HIV-1 drug resistance mutations among individuals with low-level viraemia while taking combination ART in Botswana Journal of Antimicrobial Chemotherapy, 2022 DOI:10.1093/jac/dkac056

[3]	HIV-1C in-House RNA-Based Genotyping Assay for Detection of Drug Resistance Mutations in Samples with Low-Level Viral Loads Infection and Drug Resistance, 2022 DOI:10.2147/IDR.S388816

[4]	Persistent low-Level viremia in persons living with HIV undertreatment: An unresolved status Virulence, 2021 DOI:10.1080/21505594.2021.2004743

[5]	Persistent low-Level viremia in persons living with HIV undertreatment: An unresolved status Virulence, 2021 DOI:10.1080/21505594.2021.2004743

[6]	Feasibility and clinical relevance of HIV-1 drug resistance testing in patients with low-level viraemia in South Africa Journal of Antimicrobial Chemotherapy, 2021 DOI:10.1093/jac/dkab220

[7]	Human Immunodeficiency Virus (HIV) Drug Resistance: A Global Narrative Review Journal of Biomedical Research & Environmental Sciences, 2021 DOI:10.37871/jbres1323

[8]	Persistent low-Level viremia in persons living with HIV undertreatment: An unresolved status Virulence, 2021 DOI:10.1080/21505594.2021.2004743

[9]	Drug resistance mutations in proviral DNA of HIV-infected patients with low level of viremia Journal of Clinical Virology, 2020 DOI:10.1016/j.jcv.2020.104657

[10]	Low rates of nucleoside reverse transcriptase inhibitor and nonnucleoside reverse transcriptase inhibitor drug resistance in Botswana AIDS, 2019 DOI:10.1097/QAD.0000000000002166

[11]	Tuberculous meningitis is associated with higher cerebrospinal HIV-1 viral loads compared to other HIV-1-associated meningitides PLOS ONE, 2018 DOI:10.1371/journal.pone.0192060

[12]	HIV drug resistance detected during low-level viraemia is associated with subsequent virologic failure AIDS, 2014 DOI:10.1097/QAD.0000000000000203

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

World Journal of AIDS

World Journal of AIDS

Journals Menu

Home

About SCIRP

Service

Policies